Open Access

Carotid artery stiffness, digital endothelial function, and coronary calcium in patients with essential thrombocytosis, free of overt atherosclerotic disease

, , ,  and   
Jan 14, 2017

Cite
Download Cover

Recruitment of essential thrombocytosis (ET) and control subjects for the cross-sectional study of endothelial function and preclinical atherosclerosis.
Recruitment of essential thrombocytosis (ET) and control subjects for the cross-sectional study of endothelial function and preclinical atherosclerosis.
Correlation of the Framingham coronary heart disease (CHD) risk and coronary calcification (Agatston score). While a significant Pearson correlation between the Framingham CHD risk and the Agatston score was found for control subjects (r = 0.577, p < 0.001), no significant correlation was found for the patients with essential thrombocytosis (ET).
Correlation of the Framingham coronary heart disease (CHD) risk and coronary calcification (Agatston score). While a significant Pearson correlation between the Framingham CHD risk and the Agatston score was found for control subjects (r = 0.577, p < 0.001), no significant correlation was found for the patients with essential thrombocytosis (ET).

Coronary calcium burden_ Median and interquartile range are given for the Agatston score of coronary calcification, and the number of subjects with an Agatston score of > 160 is given_ The comparison between groups were tested by χ-square1- or Mann-Whitney test2

Coronary calcuim burdenET patients (n= 40)Control group (n= 42)Comparison between groups (p)
2Agatston score0.1 (0-16.85)0 (0-8.55)0.26
1Agatston score > 160 (yes/no)6/340/42<0.01

Endothelial function of the digital arteries - reactive hyperemia index (RHI) and estimate of vascular stiffness - augmentation index (AI)_ Means and standard deviations are given for the normally distributed RHI, medians and interquartile range are given for non-normally distributed AI_ Comparisons between groups were tested by the Student’s t-test1, or the Mann-Whitney test2

ET patients (n= 40)Control group (n= 42)Comparison between groups (p)
1RHI2.10 (0.57)2.35 (0.62)0.07
2AI [%]19 (3-30)13 (5-22)0.38

Blood cell count and C-reactive protein (CRP)_ Mixed cells denote a composite reading for monocytes, eosinophils and basophils_ When CRP was reported as < 5 mg/L, a value of 2_5 mg/L was ascribed to the subject, therefore the CRP values are only an approximation_ Mean and standard deviation are shown for normally distributed data; median and interquartile range are given for non-normally distributed data_ The comparisons between groups were tested by Student’s t-test1, or by Mann-Whitney test2

VariableET patients (n= 40)Control group (n= 42)Comparison between groups (p)
1Red blood cells [10^12/L]4.37 (0.67)4.76 (0.41)<0.01
1 Platelets [10^9/L]509 (182)243 (53)<0.001
1Leukocytes [10^9/L]7.60 (3.00)7.02 (1.63)0.28
1Lymphocytes [10^9/L]1.67 (0.80)2.23 (0.75)<0.01
1 Neutrophils [10^9/L]5.15 (2.48)4.15 (1.20)0.02
2Mixed cells [10^9/L]0.6 (0.4-0.9)0.6 (0.5-0.7)0.76
2CRP [mg/L]5.0 (2.5-8.4)5.4 (2.5-6.1)0.27

Asymptomatic carotid plaques, carotid β-stiffness index and estimated pulse wave velocity_ Mean and standard deviation are given for normally distributed continuous data, median and interquartile range are given for non-normally distributed continuous data and the number of subjects with a carotid plaque score of ≥2 is given_ Comparisons between groups were tested by: χ-square1, Student’s t-test2, or the Mann-Whitney test3

ET patients (n= 40)Control group (n= 42)Comparison between groups (p)
3 Carotid plaque score1 (0-1.25)0 (0-2)0.30
1 Carotid plaque score ≥2 (yes/no)10/3014/280.41
2β-stiffness index7.75 (2.34)8.44 (2.81)0.23
2pulse wave velocity (m/s)6.21 (1.00)6.45 (1.04)0.46

Cardiovascular 10-year risk estimation by the Framingham risk equations_ Median and interquartile range are shown_ Comparisons between groups were tested by the Mann-Whitney test

Framingham 10-year risk calculation (%)ET patients(n= 40)Control group (n= 42)Comparison between groups (p)
CHD7.80 (3.98-13.73)7.20 (3.57-11.37)0.52
MI2.87 (1.25-6.72)2.17 (0.77-4.73)0.47
Stroke2.93 (1.19-5.37)2.59 (1.49-4.09)0.73
CVD14.56 (7.16 – 23.68)12.99 (6.43-19.52)0.84

Baseline characteristics_ Numbers of subjects are given for discrete data_ Mean and standard deviation are shown for normally distributed continuous data; median and interquartile range are given for non-normally distributed continuous data_ Comparisons between groups were tested by χ-square1, Student’s t-test2, or Mann-Whitney test3

VariableET patients (n= 40)Control group (n= 42)Comparison between groups (p)
2 Age (years)57.1 (14.1)58.2 (13.1)0.71
1 Sex (M/F)14/2616/260.77
2 BMI (kg/m2)25.4 (3.5)27.0 (4.5)0.07
2 Waist circumference (cm)
M95.4 (10.4)101.1(10.2)0.14
F89.7 (8.8)89.4 (13.6)0.92
3 Systolic blood pressure (mmHg)139 (129-148)136 (130-143)0.33
3 Diastolic blood pressure (mmHg)80 (73-89)80 (74-87)0.92
2Total cholesterol (mmol/l)5.01 (1.07)5.23 (0.83)0.30
2LDL-cholesterol (mmol/l)2.73 (0.77)2.86 (0.69)0.42
2HDL-cholesterol (mmol/l)1.44 (0.48)1.63 (0.48)0.07
2Triglycerides (mmol/l)1.82 (0.79)1.65 (0.82)0.33
1 Current smoking (yes/no)5/353/390.41
1 Ever smoking (yes/no)16/2411/310.12
1Diabetes (yes/no)3/370/420.07
3Serum glucose (mmol/l)5.4 (4.7-6.1)5.1 (4.8-5.6)0.64
Kidney disease (yes/no)0/400/42-
2Serum creatinine (μmol/l)75.7 (15.0)75.7 (14.1)0.99
Family history of premature CVD (yes/no)0/400/42-
1Family history of CVD (yes/no)16/2416/260.86
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology